A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Coherus Oncology, Inc.
Novartis
EMD Serono
Eli Lilly and Company
Pfizer
Ohio State University Comprehensive Cancer Center
Pfizer
AstraZeneca
City of Hope Medical Center
GlaxoSmithKline
Pfizer
Eli Lilly and Company
City of Hope Medical Center
Enliven Therapeutics
University of Alabama at Birmingham
Toray Industries, Inc
City of Hope Medical Center
DEKA Biosciences
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Hansoh BioMedical R&D Company
IGM Biosciences, Inc.
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Tanta University
Hansoh BioMedical R&D Company
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Taiho Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co. Ltd
Shanghai Zhongshan Hospital
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Ludwig Institute for Cancer Research
Sumitomo Pharma Co., Ltd.
GSO Global Clinical Research BV
Gilead Sciences
Eli Lilly and Company
TG Therapeutics, Inc.
M.D. Anderson Cancer Center
mAbxience Research S.L.
Haihe Biopharma Co., Ltd.
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
University of Miami